
Rigel Pharmaceuticals Names Alison L. Hannah as Chief Medical Officer
After serving on the board of directors since 2021, Dr. Alison L. Hannah has resigned her seat to take the reins as Rigel Pharmaceuticals' new executive vice president and chief medical officer. She succeeds Dr. Lisa Rojkjaer, stepping into the role effective July 1, 2026, to oversee the company's clinical pipeline.

























